Monitoring Concordance in the Management of Transfusing Blood Components in Cirrhotic Patients for Paracentesis with Evidence-Based Guidelines

Authors

Joseph Kim, HCA HealthcareFollow
Gregory Moses, HCA HealthcareFollow

Files

Division

North Texas

Hospital

Medical City Weatherford

Specialty

Internal Medicine

Document Type

Poster

Publication Date

4-28-2023

Keywords

chronic liver disease, blood testing, quality improvement

Disciplines

Digestive System Diseases | Internal Medicine | Pathology | Quality Improvement | Therapeutics

Abstract

Initiative to decrease unnecessary hemostatic agent transfusion in cirrhotic patients undergoing paracentesis: a resident-led approach quality improvement project to prevent transfusion overuse. Currently, there is no official guideline placed in the hospital for the administration of a hemostatic agent such as fresh frozen plasma in the setting of an elevated international normalized ratio, which paradoxically is an anticipated finding in cirrhotic patients. This process leads to unnecessarily prolonging the duration of the hospital course due to delays in performing the interventional procedures and interruptions in scheduling. The goal of this project is to educate and provide physicians with the most recent guidelines for managing bleeding risks with periprocedural procedures.

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Kim, Joseph and Moses, Gregory, "Monitoring Concordance in the Management of Transfusing Blood Components in Cirrhotic Patients for Paracentesis with Evidence-Based Guidelines" (2023). North Texas Research Forum 2023. 4.
https://scholarlycommons.hcahealthcare.com/northtexas2023/4